SV2003001422A - "1,3-diarilprop-2-en-1-onas,composiciones que las contienen y su utilizacion" - Google Patents

"1,3-diarilprop-2-en-1-onas,composiciones que las contienen y su utilizacion"

Info

Publication number
SV2003001422A
SV2003001422A SV2002001422A SV2002001422A SV2003001422A SV 2003001422 A SV2003001422 A SV 2003001422A SV 2002001422 A SV2002001422 A SV 2002001422A SV 2002001422 A SV2002001422 A SV 2002001422A SV 2003001422 A SV2003001422 A SV 2003001422A
Authority
SV
El Salvador
Prior art keywords
diarilprop
onas
compositions
contain
oncology
Prior art date
Application number
SV2002001422A
Other languages
English (en)
Spanish (es)
Inventor
Patrick Mailliet
Cecile Combeau
Marie Christine Bissery
Marie Pierre Cherrier
Thomas Caulfield
Gilles Tiraboschi
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115739A external-priority patent/FR2833008B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of SV2003001422A publication Critical patent/SV2003001422A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32—N-nitroguanidines
    • C07C279/36—Substituted N-nitroguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SV2002001422A 2001-12-05 2002-12-02 "1,3-diarilprop-2-en-1-onas,composiciones que las contienen y su utilizacion" SV2003001422A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0115739A FR2833008B1 (fr) 2001-12-05 2001-12-05 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR0214217 2002-11-14

Publications (1)

Publication Number Publication Date
SV2003001422A true SV2003001422A (es) 2003-07-10

Family

ID=26213287

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2002001422A SV2003001422A (es) 2001-12-05 2002-12-02 "1,3-diarilprop-2-en-1-onas,composiciones que las contienen y su utilizacion"

Country Status (23)

Country Link
EP (1) EP1453790A2 (fr)
JP (1) JP2005531494A (fr)
KR (1) KR20050044712A (fr)
CN (1) CN1612856A (fr)
AR (1) AR037479A1 (fr)
AU (1) AU2002365644A1 (fr)
BR (1) BR0214694A (fr)
CA (1) CA2469193A1 (fr)
CO (1) CO5580759A2 (fr)
EA (1) EA006803B1 (fr)
HR (1) HRP20040508A2 (fr)
HU (1) HUP0500100A2 (fr)
IL (1) IL162223A0 (fr)
MA (1) MA27351A1 (fr)
MX (1) MXPA04005226A (fr)
NZ (1) NZ533224A (fr)
PA (1) PA8558501A1 (fr)
PE (1) PE20030758A1 (fr)
PL (1) PL370676A1 (fr)
RS (1) RS47804A (fr)
SV (1) SV2003001422A (fr)
TW (1) TW200300685A (fr)
WO (1) WO2003048106A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854399B1 (fr) * 2003-04-30 2006-11-17 Aventis Pharma Sa 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation
EP1598353A1 (fr) * 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolones et leur utilisation en tant qu'agents antiproliferatifs
WO2017103637A1 (fr) 2015-12-18 2017-06-22 Blirt S.A. Composés de diphénylpropane et leur activité cytotoxique
CN109467549B (zh) * 2018-12-07 2021-02-09 中国药科大学 喹啉取代查尔酮类化合物、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
JPH08277242A (ja) * 1995-02-08 1996-10-22 Kyowa Hakko Kogyo Co Ltd プロペノン誘導体
BR9607708A (pt) * 1995-12-01 1998-01-13 Kyowa Hakko Kogyo Kk Derivado de propenona
WO1999000114A2 (fr) * 1997-06-26 1999-01-07 Statens Serum Institut 1,3-bis-aromatique-prop-2-en-1-ones, 1,3-bis-aromatique-propane-1-ones et 1,3-bis-aromatique-prop-2-yn-1-ones a action biologique

Also Published As

Publication number Publication date
JP2005531494A (ja) 2005-10-20
RS47804A (en) 2006-12-15
MXPA04005226A (es) 2004-10-11
EP1453790A2 (fr) 2004-09-08
CA2469193A1 (fr) 2003-06-12
HRP20040508A2 (en) 2005-08-31
HUP0500100A2 (hu) 2005-05-30
IL162223A0 (en) 2005-11-20
MA27351A1 (fr) 2005-06-01
EA006803B1 (ru) 2006-04-28
KR20050044712A (ko) 2005-05-12
AR037479A1 (es) 2004-11-10
BR0214694A (pt) 2004-12-14
WO2003048106A2 (fr) 2003-06-12
CO5580759A2 (es) 2005-11-30
WO2003048106A3 (fr) 2004-03-25
EA200400764A1 (ru) 2004-12-30
AU2002365644A1 (en) 2003-06-17
PA8558501A1 (es) 2003-09-05
NZ533224A (en) 2006-03-31
PL370676A1 (en) 2005-05-30
CN1612856A (zh) 2005-05-04
PE20030758A1 (es) 2003-10-07
TW200300685A (en) 2003-06-16

Similar Documents

Publication Publication Date Title
SV2003001493A (es) Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
CR8767A (es) Indazoles sustituidos, composiciones que los contienen, procedimiento de preparacion y su uso
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
SE0101387D0 (sv) Novel compounds
HN2002000030A (es) Nueva sal succinato de o-desmetil-venlafaxina
SV2003000925A (es) Derivados espirotriciclicos nuevos y su uso como inhibidores de fosfodiesterasa-7
NO20050426L (no) Arylkarbonylderivater som terapeutiske midler
DK1480615T3 (da) Superfin formoterolformulering
NO20033565L (no) Acylerte indanylaminer og deres anvendelse som farmasöytiske midler
NO20033566L (no) Acylerte 6,7,8,9-tetrehydro-5H-benzocykloheptenyl-aminer og deres anvendelse som farmasöytiske midler
HN2001000027A (es) Derivados de purina
DK1525177T3 (da) Substituerede 1,3-diphenylprop-2-en-1-on-derivater, fremstilling og anvendelse deraf
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
DK1484970T3 (da) Benzamider og sammensætninger omfattende benzamider til anvendelse som fungicider
AR109263A2 (es) Composición que comprende moxidectina
HN2002000150A (es) Agentes antibacteriano
ATE445389T1 (de) Liposomale glucocorticoide
SE0101932D0 (sv) Pharmaceutical combinations
DK1513835T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
DK1330244T3 (da) Præparater der omfatter modafinilforbindelser
HN2002000278A (es) Tetrahidroquinolinas

Legal Events

Date Code Title Description
FG Grant
FD Lapse